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1. Introduction 
The most convincing evidence for the existence of 
mitochondrial transporters is the ability shown by 
certain respiratory poisons to prevent specific ex- 
change ‘diffusion’ reactions across the inner mitochon- 
drial membrane [ 1,2]. The absence of such a transport 
inhibitor for monocarboxylates has cast doubt that 
the ready penetration and exchange of pyruvate 
across the mitochondrial inner membrane [3-61 is 
mediated by a carrier; indeed it has been argued [2] 
that sufficient undissociated monocarboxylic acid 
exists in the cell to render redundant such a transport- 
er. Very recently some data on the influence of (Y- 
cyano-4-hydroxycinnimate on red cell and mitochon- 
drial pyruvate content have been interpreted to mean 
that this compound is a specific inhbitor of pyruvate 
transport in these vesicles [7]. 
This report presents some studies of the effect of 
certain 2-oxo-acids on pyruvate content, pyruvate 
exchange reactions and pyruvate oxidation in rat 
liver mitochondria. The results are interpreted as 
evidence for the existence of a monocarboxylate 
transporter. Palmityl carnitine has been found to be 
a very powerful counter-transporter of pyruvate. The 
consequences of such an exchange in the control of 
the pyruvate dehydrogenase complex are discussed. 
2. Materials and methods 
Mitochondria from livers of male white rats weigh- 
ing about 230-250 g were prepared and twice washed 
in 0.25 M sucrose; 2.5 mM triethanolamine-HCl; 1 
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mM ethylene diamine tetraacetic acid buffer, pH 7.2. 
Finally they were resuspended at about 50 mg per ml 
in incubation buffer minus rotenone and arsenite. 
In exchange experiments the medium contained 0.25 
M sucrose; 10 mM KCl; 20 mM Tris-HCl; 1.15 mM 
succinate; 21.5 mM oxamate; 0.75 mM arsenite, pH 
7.4. This buffer also invariably contained 2.5 pg 
rotenone and about 10 PCi f3 H]HZ 0 per ml. The 
procedure used in exchange experiments was that 
concentrated mitochondrial suspension was added to 
about 2 ml of incubation buffer at 25°C containing 
1 mM [U-’ 4 C] pyruvate so that the final mitochon- 
drial concentration was about 5 mg per ml. After 3 
min incubation, 200 ~1 samples of the suspension 
were centrifuged as described below. A small volume 
(5 or 10 ~1) of competing unlabelled substrate (100 
or 300 mM) was now added to the incubation and 
the mixture sampled after a further 2 min. Further 
additions of competing substrate were followed by 
incubation and sampling. Oxygen electrode experi- 
ments were performed in 0.13 M KCl; 2 mM MgC12; 
2 mM EGTA; 5 mM Tris-HCl; 2% defatted albumin 
solution, pH 7.2. The electrode chamber (Rank Bros., 
Bottisham, Cambridgeshire) contained in addition to 
about 3 mg mitochondrial protein in 1.5 ml buffer, 
2 pmoles D-glucose and inorganic phosphate, 10 
mnoles ADP and 50 pmoles D-glucose and inorganic 
phosphate, 10 nmoles ADP and 50 pg yeast hexokinase 
(Boehringer). 
[U-’ 4 C] pyruvate was obtained from the Radio- 
chemical Centre, Amersham, and used at a specific 
activity of 135 mCi per mole. a-Ketovaleric acid 
(KV) and a-ketoisocaproic acid (KIC) were obtained 
from Fluka AG, Buchs SG, Switzerland, L-carnitine 
North-Holland Publishing Company - Amsterdam 
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and phenylpyruvic acid from Kochlight, Colnbrook, 
Bucks, and DL-palmityl camitine from Sigma London 
Chemical Company Ltd. The substrate content of the 
mitochondria was measured after sedimenting about 
1 mg mitochondria through DC550 silicone oil (Hop- 
kins & Williams Ltd., Chadwell Heath, Essex) into 1.5 
M HCIO,, in a Zentrifuge 3200 (Eppendorf, Marburg/ 
Lahn) as described by Harris and Van Dam [8]. The 
extramitochondrial space was determined in parallel 
experiments using [’ 4 C] sucrose and protein was 
estimated by the method of Lowry et al. [9]. 
3. Experimental 
3.1. Pyruvate exchange 
Fig. 1 presents results from experiments in which 
following incubation in 1 mM [r4C]pyruvate, the 
effect of addition of unlabelled pyruvate on the intrami- 
tochondrial radioactivity has been measured. At con- 
centrations of pyruvate in suspending medium above 
1 mM, the mitochondrial pyruvate content does not 
substantially increase. Although certain anions are 
capable of co-transporting pyruvate in rat liver and 
heart mitochondria and thus, on addition, of increasing 
the level of intramitochondrial pyruvate they appear 
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Fig. 1. [‘4C]pyruvate loaded mitochondria were incubated 
at 25°C after addition of no inhibitor (o), 50 mM cu-ketovaler 
ate (m) or or-ketoisocaproate (0) followed by further addi- 
tion to give the concentration shown of unlabelled pyruvate 
to the original 1 mM [“C]pyruvate medium. The radioacti- 
vity in the sucrose inaccessible space was determined after 
centrifugation of about 1 mg of mitochondria through sili- 
cone oil. The initial [“‘Clpyruvate content was 1.10 f 0.07 
nmoles per mg protein and the data show the mean and 
S.E.M. of 4 different preparations. A represents the content 
when either KV or KIC were added prior to the [“Clpyru- 
vate. 
to influence only the maximum pyruvate content 
and not the affinity of the mitochondria for pyruvate 
(J. Mowbray, unpublished results). This being so, 
further addition of unlabelled pyruvate to the [ l4 Cl- 
pyruvate incubation will be expected to reduce the 
intramitochondrial radioactivity if free exchange 
between medium and mitochondrial pyruvate exists. 
In the absence of inhibitor this is indeed what happens 
(fig. 1). The values found are very close to those 
predicted from the known reduction in pyruvate 
specific activity. When, following the initial incubation 
in [14C]pyruvate, lOO@ of a 1 M solution in buffer 
of either 2-ketovalerate or 2-ketoisocaproate is added 
(50 mM final concentration) and incubation continued 
for a further 2 min before sampling, the response to 
unlabelled pyruvate addition is quite different. In 
neither case does the addition of unlabelled pyruvate 
substantially alter the initial radioactivity in the su- 
crose impermeable space. This is behaviour consistent 
with that expected of compounds which inhibit 
pyruvate transport. However, the addition of these 
inhibitors, by themselves, caused an appreciable reduc- 
tion in the [14 C] pyruvate content, especially in the 
case of KV where the initial content drops by 60%. 
In these experiments the sucrose-inaccessible space 
had values between 0.65 and 0.88 ~1 per mg protein 
and was not observed to be altered by additions of 
substrate or inhibitors. The displacement of pyruvate 
from mitochondria is presumably the result of compe- 
tition by the inhibitors for pyruvate binding sites, 
including the transporter. The different amounts of 
displacement shown by different inhibitors may 
reflect their ability as competitors at several distinct 
substrate sites. Interestingly KV has been reported 
to have a substantially smaller Km for pig heart 
pyruvate dehydrogenase complex than KIC: also that 
KIC has no effect on brain pyruvate dehydrogenase 
[ 11 ,121 though it inhibits brain citrate synthase [ 121. 
For the obvious reason that it reduces the pyruvate 
content less, KIC seems preferable as a possible 
transport inhibitor. When either KIC or KV were add- 
ed prior to [’ 4 C] pyruvate, the initial pyruvate con- 
tent was less than 10% of the control value. Very 
similar results to those shown in fig. 1 were obtained 
if the unlabelled pyruvate were replaced by DL-3- 
hydroxybutyrate. Phenylpyruvate at 23 mM behaves 
much like KIC: it reduces the mitochondrial pyruvate 
content by about 45%. 
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Fig. 2. The inhbition of extra oxygen uptake (23 natoms 
O.mg-’ min-’ .) shown by state 3 rat liver mitochondria 
after 0.6 mM pyruvate addition (0). At this concentration 
extra oxygen uptake due to pyruvate was proportional to 
pyruvate concentration. No exogenous malate was provided 
since malate addition has been found to alter pyruvate 
. penetration to the sucrose-impermeable space. The hyper- 
bolic curve obtained by correcting the original data for the 
linear component which is observable above 3 mM inhibitor 
concentration has been plotted Cm). 
3.2. Oxygen electrode studies 
Not surprisingly, KIC was found to be a powerful 
inhibitor of pyruvate oxidation in whole coupled 
mitochondria, being capable of inhibiting the extra 
oxygen uptake due to pyruvate by 80% at 11 mM 
(fig. 2). The initial inhibition is severe reaching 60% 
by 3 mM inhibitor. Increases in KIC concentration 
between 3 and 11 mM appear to exert a linear in- 
crease in the inhibition. Assuming this linear com- 
ponent to have been present from the beginning, the 
effect of the inhibitor has been divided into a satur- 
able component inhibiting 50% of the extra oxygen 
uptake by 3 mM KIC and a less powerful inhibitory 
function which does not show saturation within the 
concentration range used. It is worth noting that be- 
cause of the ‘catalytic’ effect of added substrates on 
oxygen uptake the degree of inhibition in this ex- 
periment cannot be directly compared with the ex- 
change experiments. However these data would suggest 
that KIC may be having at least two distinct effects in 
mitochondria; which effect might be assigned to 
transporter inhibition is uncertain. It is notable how 
similar these results are to KIC inhibition of pyruvate 
oxidation in whole brain mitochondria [ 131 where 
KIC inhibits citrate synthase [ 121 but not extracted 
pyruvate dehydrogenase. Thus it is possible that the 
two inhibitory effects seen represent transporter and 
citrate synthase inhibition. 
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3.3. The effect of palmityl carnitine on pyruvate con- 
tent 
Of the ions observed to undergo exchange reactions 
with pyruvate across the liver mitochondrial mem- 
brane, DLpalmityl carnitine has been found to be 
by far the most effective in expelling pyruvate. At 
0.2 mM Dl-palmityl carnitine reduces the liver mito- 
chondrial pyruvate content by 80% in the presence 
of 2.2 mM pyruvate (fig. 3). L-carnitine itself, at 5 
mM, reduces the pyruvate in the sucrose-inaccessible 
space by 6%. 
[palmityt camitice] yM 
Fig. 3. The effect of DL-palmityl carnitine in the presence 
of 2.2 mM pyruvate on the content of pyruvate in the 
sucrose inaccessible space (1.06 ~1 per mg) of rat liver 
mitochondria. The initial pyruvate content was 1.19 nmoles 
per mg protein and the data are means from two experiments 
4. Discussion 
The addition of high concentrations of KV, KIC 
and phenylpyruvate appear capable of sequestering 
within intact mitochondria a pool of pyruvate such 
that it will not exchange with pyruvate in the suspend- 
ing medium. This appears strong evidence for the 
specific inhibition of pyruvate transport in mitochon- 
dria. Attempts to inhibit pyruvate exchange with 
hemimellitate or 2-n-butyl malonate were unsuccess- 
ful (J. Mowbray, unpublished results) implying that 
the operation of the dicarboxylate or tricarboxylate 
carriers are not required for pyruvate transport. 
Butyl malonate (15 mM), however, did reduce the 
pyruvate content by 5%. In the light of this and in 
view of the fact that any ion which counter-exchanges 
pyruvate may reduce the pyruvate content, it is 
necessary to interpret with caution experiments 
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where a proposed transport inhibitor is shown merely 
to have reduced the quantity of anion sequestered 
[cf. 71. Under conditions where pyruvate efflux ap- 
pears small and where pyruvate oxidation was prob- 
ably low, a-cyano-4-hydroxycinnimate addition (0.5 
mM) allowed recovery of more intramitochondrial 
pyruvate after centrifugation of mitochondria than 
in the absence of inhibitors ]7 1. These results are 
consistent with the suggestion that this compound 
too may be a transport inhibitor, and that the trans- 
porter recognises the enol form of a-oxo-acids [7]. 
A striking similarity has been found between 
pyruvate and 3-hydroxybutyrate in exchange experi- 
ments and it seems possible that these compounds 
share a carrier. In support of this it has been found 
that the Ki for pyruvate inhibition of hydroxybuty- 
rate transport has the same value as the absorption 
coefficient for pyruvate (J. Mowbray, unpublished 
results). If this is so, counter-exchange of pyruvate 
and 3-hydroxybutyrate across the mitochondrial 
membrane may explain the sparing effect of ketone 
bodies on glucose utilisation in peripheral tissues, 
since expulsion of pyruvate would lead to inhibition 
of the pyruvate dehydrogenase complex. The propor- 
tion of this complex in the active (dephospho) form 
appears to depend on the supply of pyruvate [ 141, 
possibly because pyruvate protects the complex 
from kinase attack [15,16]. Incubation of whole rat 
liver mitochondria with pyruvate has been shown to 
lead to activation of pyruvate dehydrogenase: also 
palmityl carnitine and 3-hydroxybutyrate can reverse 
this effect [ 171. Significantly, pynivate was maximally 
effective in activating the complex at 2 mM, and half- 
maximal activation was achieved around 0.4 mM [ 171. 
The Langmuir absorption constant (equivalent to 
K,) for pyruvate sequestration in liver mitochondria 
has been found to be 0.45 mM (J. Mowbray, unpublish- 
ed results) and the pyruvate content to be maximal at 
a medium concentration of 2 mM. Further, Porten- 
haus and Wieland [ 171 found 100 PM L-palmityl 
carnitine to be maximally effective in reversing pyru- 
vate activation of the complex; this concentration 
compares well with the 200 PM DL-palmityl carnitine 
found to expel virtually all the mitochondrial pyruvate 
(fig. 3). Since pyruvate dehydrogenase appears only 
accessible from the matrix space [ 181, it seems likely 
that the mechanism by which ketone bodies and fatty 
acid carnityl derivatives achieve their effect on pyru- 
vate oxidation in through the specific expulsion of 
mitochondrial pyruvate via the transporter and the 
subsequent effect of this on the covalent modification 
of the complex. 
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